2018 has been a busy year for the molecular department. Two new assays have been added to our molecular test menu; APTIMA HSV 1 & 2 and the BD AFFIRM VAGINITIS PANEL.
The Aptima HSV 1 & 2 assay is a fully automated, real time nucleic acid amplification test that will qualitatively detect and differentiate between HSV-1 and HSV-2. The assay is only for active anogenital skin lesions collected in the Aptima Multi test swab. The assay yields results in 2.7 hours after the start of testing as opposed to several days with traditional culture methods.
The BD Affirm Vaginitis Panel is available from a swab that tests for the presence of DNA from Trichomonas, Gardnerella bacteria and seven types of Candida. It does not differentiate the types of Candida but is a rapid test for the most common causes of vaginitis.
Tulsa Medical lab has also been validated for testing chlamydia and gonorrhea mRNA from urine samples utilizing the Aptima Combo 2 assay on the Hologic Panther system.
In addition to HPV testing with high risk genotyping for pap smears, the Aptima high risk HPV and the Aptima Genotyping assays are also available for anal pap samples.